Summarized by Masters of Longevity from Frontiers - Health.
A lab study previewing research on a small-molecule that stimulates neuronal autophagy and lowers a disease-relevant phosphorylated protein in patient-derived neurons, useful for readers interested in experimental therapeutic strategies for neurodegeneration.
Key Takeaways
- Dibucaine triggered autophagic flux in rat primary neurons and human iPSC-derived neuronal models.
- In iPSC-derived dopaminergic neurons with SNCA duplication, dibucaine reduced cellular levels of Ser129-phosphorylated α-synuclein.
- Dibucaine increased AMPK Thr172 phosphorylation in SH-SY5Y cells and LY364947 partly attenuated LC3-II accumulation.
